covid
Buscar en
Endocrinología y Nutrición (English Edition)
Toda la web
Inicio Endocrinología y Nutrición (English Edition) Reference values and universal screening of thyroid dysfunction in pregnant wome...
Información de la revista
Vol. 61. Núm. 6.
Páginas 336-338 (junio - julio 2014)
Vol. 61. Núm. 6.
Páginas 336-338 (junio - julio 2014)
Scientific Letter
Acceso a texto completo
Reference values and universal screening of thyroid dysfunction in pregnant women
Valores de referencia y cribado universal de la disfunción tiroidea en la mujer gestante
Visitas
2680
Gonzalo Díaz-Sotoa,
Autor para correspondencia
diazsotogonzalo@gmail.com

Corresponding author.
, Encarna Largob, Cristina Álvarez-Colomoc, Isabel Martínez-Pinod, Daniel de Luisa
a Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
b Servicio de Análisis Clínicos, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
c Servicio de Ginecología y Obstetricia, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
d Servicio Territorial de Sanidad y Bienestar Social, Zamora CIBERESP Instituto de Salud Carlos III, Madrid, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Normal TSH and FT4 levels in the Spanish population with negative autoimmunity.
Texto completo

Universal thyroid function screening in pregnant women is one of the most controversial issues in current endocrinology. In contrast to the American Thyroid Association (ATA) clinical guidelines, which recommend selective screening in the population at risk,1 other scientific societies, including the Spanish Society of Endocrinology and Nutrition (SEEN), advocate universal screening in the pregnant population.2 However, reference ranges for thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels in pregnant women proposed by the ATA are assumed without the necessary critical assessment. An article published by Lombardo Grifol et al. emphasizes this, as had already been done by the prior studies published in the dissemination organ of SEEN.3

It is particularly significant that TSH reference ranges in Spanish populations from very distant geographical areas, obtained using different laboratory procedures and statistical methods, greatly differ from those recommended by international guidelines (TSH<2.5μUI/ml during the first trimester of pregnancy) and are very similar to each other.3–8

On January 2013, the Hospital Clínico Universitario in Valladolid started universal thyroid function screening in pregnancy in collaboration with the departments of gynecology and obstetrics and clinical laboratory. During 2013, TSH and FT4 levels and thyroid autoimmunity were retrospectively tested in 1.316 women (mean age: 32.6±5.6 years) in the week 10 of pregnancy (Cobas® 6000, Roche Diagnostics). One hundred and sixty women were excluded for positive autoimmunity (115 women, 8.7%), prior thyroid disease and/or treatment modifying thyroid profile. Reference ranges for TSH and FT4 in week 10 of pregnancy were calculated according to recommendations by the Internacional Federation of Clinical Chemistry (IFCC). For this, distribution of FT4 and TSH levels was normalized by logarithmic transformation, and confidence intervals for the 2.5th and 97.5th percentiles, corresponding to the lower and upper limits of the reference values respectively, were subsequently calculated.9

The results recorded in our population are similar to those previously reported for the Spanish population, with minimal differences attributable to the gestational week, the procedure used, and the area of origin (Table 1),3–8 but significantly differ from those recommended by the ATA and SEEN.1,2 This striking situation is not unique, because recent studies reported similar reference ranges in healthy pregnant women from other countries. This stresses the importance of calculating reference ranges for each laboratory.10 In this regard, it should be noted that American and Spanish guidelines advise TSH levels under 2.5μUI/ml only if no reference values are available for procedures used and for the same study population during the first trimester. However, in light of the results, hormone levels in Spanish populations are consistently higher regardless of the procedure used and the population tested. This should be reflected in the future in the clinical guidelines/recommendations published by the SEEN in this regard. It should not be forgotten that no adequate scientific evidence is available on the efficacy of treatment for subclinical hypothyroidism with TSH levels higher than 2.5μUI/ml in pregnant women.11,12

Table 1.

Normal TSH and FT4 levels in the Spanish population with negative autoimmunity.

Study, year of publication  Population  Gestational weeks  Laboratory  No.  TSH (μIU/mL)FT4 (ng/dL)
          P 2.5th (90% CI)  P 97.5th (90% CI)  P 2.5th (90% CI)  P 97.5th (90% CI) 
Bocos Terraz et al., 20094  Saragossa  <14  Abbot  481  0.41  2.63  0.83  1.38 
Vila et al., 20105  Catalonia  Bayer  178  0.12  4.75  0.80  1.60 
García Guadiana et al., 20106  Cartagena  11–13  Roche  400  0.13  3.71  0.89  1.50 
Santiago et al., 20117  Jaén  7–10  Beckman  305  0.23  4.18  0.60  1.06 
Aller Granda et al., 20138  Oviedo  6–12  Roche  264  0.17  4.15  –  – 
Lombardo Grifol et al., 20133  El Bierzo  8–13  Bayer  219  0.497 (0.415–0.584)  3.595 (3.298–3.914)  0.90 (0.88–0.92)  1.42 (1.39–1.45) 
Díaz-Soto et al., 2014  Valladolid  10  Roche  1156  0.27 (0.159–0.346)  4.05 (3.973–4.170)  0.94 (0.92–0.95)  1.50 (1.47–1.55) 

Data from this study are given in italics.

CI: confidence interval; P: percentile; TSH: thyroid-stimulating hormone; FT4: free thyroxine.

Setting a given reference range obviously conditions clinical practice, but also has important economic and care implications. During 2013, an upper TSH limit of 2.5μUI/ml would have implied monitoring and treatment with levothyroxine of 436 pregnant women of our population, i.e. 38%, while 130 women (11%) would have been treated based on the normal criteria calculated for our area (TSH4.05μUI/ml).

It should also be stressed that only 62 (5%) of all women diagnosed with primary hypothyroidism during 2013 had TSH levels5μUI/ml, and of these, only 7 pregnant women (0.6%) had TSH levels10μUI/ml which could be classified as having frank hypothyroidism.

In conclusion, we think that universal screening for thyroid dysfunction is warranted, because it allows for adequate diagnosis and management of a small but significant proportion of pregnant women with hypothyroidism which could affect the adequate course of pregnancy and, probably, fetal and infant development.11,12 Universalization of screening requires, however, calculation of reference values for the population and the laboratory procedure of each hospital in a given gestational week.6 This analysis should not be considered as an exceptional method in the setting of research studies, but as a test of maximal interest for care, and is mandatory before any system for screening gestational thyroid dysfunction is implemented. Setting a universal cut-off point without considering the characteristics of each population (iodine intake, subclinical autoimmune disease, etc.) not only implies a high care overload with its attendant financial expense, but also a significant psychological burden during a especially sensitive period, as well as overtreatment of a great proportion of the population with the resultant additional risk.

Funding

This study received no public or private funding.

Conflicts of interest

The authors state that they have no conflicts of interest.

References
[1]
A. Stagnaro-Green, M. Abalovich, E. Alexander, F. Azizi, J. Mestman, R. Negro, et al.
Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.
Thyroid, 21 (2011), pp. 1081-1125
[2]
J.C. Galofre Ferrater, J.J. Corrales Hernández, B. Pérez Corral, A. Canton Blanco, N. Alonso Pedrol, A. Pérez Pérez, et al.
Guía clínica para el diagnóstico y el tratamiento de la disfunción tiroidea subclínica en la gestación.
Endocrinol Nutr, 56 (2009), pp. 85-91
[3]
M. Lombardo Grifol, M.L. Gutiérrez Menéndez, L. García Menéndez, M.V. Valdazo Revenga.
Valores de referencia y estudio de la variabilidad de hormonas tiroideas en gestantes de El Bierzo.
Endocrinol Nutr, 60 (2013), pp. 549-554
[4]
J.P. Bocos-Terraz, S. Izquierdo-Álvarez, J.L. Bancalero-Flores, R. Álvarez-Lahuerta, A. Aznar-Sauca, E. Real-López, et al.
Thyroid hormones according to gestational age in pregnant Spanish women.
BMC Res Notes, 2 (2009), pp. 237
[5]
L. Vila, M. Serra-Prat, E. Palomera, R. Casamitjana, A. de Castro, G. Legaz, et al.
Reference values for thyroid function tests in pregnant women living in Catalonia, Spain.
Thyroid, 20 (2010), pp. 221-225
[6]
L. García de Guadiana Romualdo, M. González Morales, C. Martín-Ondarza González M del, E. Martín García, J. Martínez Uriarte, A. Blázquez Abellán, et al.
Evaluation of thyroid function during pregnancy: first-trimester reference intervals for thyroid-stimulating hormone and free thyroxine.
Endocrinol Nutr, 57 (2010), pp. 290-295
[7]
P. Santiago, M. Berrio, P. Olmedo, I. Velasco, B. Sánchez, E. García, et al.
Reference values for thyroid hormones in the population of pregnant women in Jaen (Spain).
Endocrinol Nutr, 58 (2011), pp. 62-67
[8]
J. Aller Granda, A. Rabal Artal.
Thyrotropin reference values in the first trimester of pregnancy.
Endocrinol Nutr, 60 (2013), pp. 405-406
[9]
H.E. Solberg.
The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits.
J Clin Chem Clin Biochem, 21 (1983), pp. 749-760
[10]
C. Li, Z. Shan, J. Mao, W. Wang, X. Xie, W. Zhou, et al.
Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?.
J Clin Endocrinol Metab, 99 (2014), pp. 73-79
[11]
R. Negro, A. Schwartz, R. Gismondi, A. Tinelli, T. Mangieri, A. Stagnaro-Green.
Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy.
J Clin Endocrinol Metab, 95 (2010), pp. 1699-1707
[12]
J.H. Lazarus, J.P. Bestwick, S. Channon, R. Paradice, A. Maina, R. Rees, et al.
Antenatal thyroid screening and childhood cognitive function.
N Engl J Med, 366 (2012), pp. 493-501

Please cite this article as: Díaz-Soto G, Largo E, Álvarez-Colomo C, Martínez-Pino I, de Luis D. Valores de referencia y cribado universal de la disfunción tiroidea en la mujer gestante. Endocrinol Nutr. 2014;61:336‐338.

Copyright © 2014. SEEN
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos